|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03347 TIGERMED
Nominal 
41.400 -0.520 (-1.240%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 3,707,560 | 14.063% | 3,250,444 | 3,358,244 | 3,710,850 | 3,594,209 |
| Cost of Sales | (2,687,044) | -- | -- | -- | -- | (2,175,881) |
| Gross Profit | 1,020,516 | -- | -- | -- | -- | 1,418,328 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (444,201) | 273.422% | (118,954) | (134,487) | 499,980 | (28,411) | |
| Profit / (Loss) on Disposal | (18,083) | -- | 626 | 1,490 | (6) | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 21,662 | -86.981% | 166,386 | 44,095 | 63,724 | 35,556 | |
| Profit / (Loss) before Taxation | (80,215) | -- | 442,689 | 690,093 | 1,599,145 | 1,479,865 | |
| Taxation | (105,256) | 31.799% | (79,861) | (132,514) | (191,055) | (162,239) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (227,688) | -- | 20,509 | (64,730) | (19,753) | (125,622) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (413,160) | -- | 383,337 | 492,849 | 1,388,337 | 1,192,004 | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 42,285 | -33.181% | 63,282 | (16,109) | (70,049) | (82,583) |
| Depreciation & Amortisation | 181,171 | -1.797% | 184,487 | 180,372 | 162,099 | 122,774 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | -48.000 | -- | 45.000 | 57.000 | 161.000 | 138.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 22.621 | -- | 24.001 | 24.007 | -- | 21.441 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -413,160 |
| %Change | -- |
| EPS / (LPS) | RMB -0.480 |
| NBV Per Share (¥) | RMB 22.621 |